1. Study on the prevention of infection in terminal cancer patients applying epidural analgesia by adding cefazolin to anesthetics: a randomized controlled trial
- Author
-
Jing-Li Yang, Yi-Ming Wu, Peng-Cheng Xie, and Zhan-Fang Li
- Subjects
Male ,Cancer Research ,Mean arterial pressure ,Visual Analog Scale ,Dose ,Visual analogue scale ,Analgesic ,Cefazolin ,Infections ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Randomized controlled trial ,030202 anesthesiology ,law ,Neoplasms ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Anesthetics, Local ,Morphine ,business.industry ,General Medicine ,Middle Aged ,Analgesia, Epidural ,Analgesics, Opioid ,Treatment Outcome ,Oncology ,Levobupivacaine ,Patient Satisfaction ,030220 oncology & carcinogenesis ,Anesthesia ,Female ,business ,medicine.drug - Abstract
Objective To observe the antibacterial effect of adding cefazolin into anesthetics in patients with terminal cancer undergoing long-term epidural analgesia. Methods Patients undergoing epidural analgesia with terminal cancer were randomly divided into two groups: the conventional drug group (group C) and the cefazolin group (group G). Both groups were given levobupivacaine and morphine, while cefazolin was added to group G. The mean arterial pressure (MAP), heart rate (HR), respiratory rates (R), visual analogue scale (VAS) scores, satisfaction and complications of patients in the two groups were observed. 3 ml of the used analgesic was taken for bacterial culture when replacing the new analgesic case. Results HR, MAP, R, VAS scores, dosages of morphine, satisfaction of the analgesic and the complications were not significantly different between the two groups (P > 0.05). The overall satisfaction of patients in group G was significantly higher than that in group C (P Conclusion Adding cefazolin to local anesthetics could effectively prevent bacterial infection and ensured the safety of epidural analgesia for patients with terminal cancer.
- Published
- 2020